Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent Update on the Development of PCSK9 Inhibitors for Hypercholesterolemia Treatment
Shakir Ahamad, Shahnawaz Ali Bhat
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 23, pp. 15513-15539
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor
Douglas G. Johns, Louis‐Charles Campeau, Puja Banka, et al.
Circulation (2023) Vol. 148, Iss. 2, pp. 144-158
Open Access | Times Cited: 67
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside
Xuhui Bao, Yongjun Liang, Hanman Chang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 56
Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events
Emanuel Raschi, Manuela Casula, Arrigo F.G. Cicero, et al.
Pharmacology & Therapeutics (2023) Vol. 250, pp. 108507-108507
Open Access | Times Cited: 34
PCSK9 Inhibitors in Cancer Patients Treated with Immune-Checkpoint Inhibitors to Reduce Cardiovascular Events: New Frontiers in Cardioncology
Vincenzo Quagliariello, Irma Bisceglia, Massimiliano Berretta, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1397-1397
Open Access | Times Cited: 26
Targeting Wnt signaling pathway with small-molecule therapeutics for treating osteoporosis
Shakir Ahamad, Mohammad Saquib, Mohd Kamil Hussain, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108195-108195
Closed Access | Times Cited: 1
Unraveling the Puzzle of Therapeutic Peptides: A Promising Frontier in Huntington’s Disease Treatment
Shakir Ahamad, Nargis Bano, Sameera Khan, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 783-815
Closed Access | Times Cited: 8
MK-0616: an oral PCSK9 inhibitor for hypercholesterolemia treatment
John R. Burnett, Amanda J. Hooper
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 10, pp. 873-878
Closed Access | Times Cited: 14
Development of a PCSK9-targeted nanoparticle vaccine to effectively decrease the hypercholesterolemia
Qiannan Fang, Xinyu Lu, Yuanqiang Zhu, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 6, pp. 101614-101614
Open Access | Times Cited: 5
Therapeutic Monoclonal Antibodies for Metabolic Disorders: Major Advancements and Future Perspectives
Pratiksha Jamadade, Neh Nupur, Krushna Ch Maharana, et al.
Current Atherosclerosis Reports (2024) Vol. 26, Iss. 10, pp. 549-571
Closed Access | Times Cited: 5
Emerging oral therapeutic strategies for inhibiting PCSK9
Nicola Ferri, Giorgia Marodin
Atherosclerosis Plus (2024) Vol. 59, pp. 25-31
Open Access | Times Cited: 5
The study on synthesis and vitro hypolipidemic activity of novel berberine derivatives nitric oxide donors
Kexin Wang, Zhixiong Li, Weicong Zhang, et al.
Fitoterapia (2024) Vol. 176, pp. 105964-105964
Closed Access | Times Cited: 4
PCSK9 affects vascular senescence through the SIRT1 pathway
Yuqin Wang, Shaoqing Cao, Zhangyu Wang, et al.
Experimental Gerontology (2025) Vol. 201, pp. 112701-112701
Open Access
A Systematic Review with Network Meta-analysis on Atherosclerosis Vaccine Based on Nonhuman Primate Model
Asyraf Muzaffar, Ayers Gilberth Ivano Kalaij, Fajar Fakri, et al.
Journal of Preventive Diagnostic and Treatment Strategies in Medicine (2025) Vol. 4, Iss. 1, pp. 18-25
Closed Access
PCSK9 Targeted Autophagosome-Tethering Compounds: Design, Synthesis, and Antiatherosclerosis Evaluation
Hongyu Wu, Ziwen Zhang, Yongxing Xue, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Exosomes, microvesicles, and other extracellular vesicles—a Keystone Symposia report
Jennifer Cable, Kenneth W. Witwer, Robert J. Coffey, et al.
Annals of the New York Academy of Sciences (2023) Vol. 1523, Iss. 1, pp. 24-37
Closed Access | Times Cited: 10
Polyphenols: A promising nutritional strategy for the prevention and treatment of hypertension
Kenichi Gotō
Studies in natural products chemistry (2024), pp. 15-54
Closed Access | Times Cited: 3
Trifluoromethylnitrone: A Versatile Building Block for Synthesizing Trifluoromethyl-Containing Heterocyclic Compounds
Mohd Abdulla, Mohd Kamil Hussain, Shakir Ahamad
Organic & Biomolecular Chemistry (2024) Vol. 22, Iss. 26, pp. 5242-5256
Closed Access | Times Cited: 3
PCSK9 in Vascular Aging and Age-Related Diseases
Dong Tan, Xin Yang, Jing Yang, et al.
Aging and Disease (2025)
Open Access
BAY-9835: Discovery of the First Orally Bioavailable ADAMTS7 Inhibitor
Daniel Meibom, Pierre Wasnaire, Kristin Beyer, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 4, pp. 2907-2940
Open Access | Times Cited: 2
Cholesterol reduction by immunization with a PCSK9 mimic
Baoshan Zhang, Gwo‐Yu Chuang, Andrea Biju, et al.
Cell Reports (2024) Vol. 43, Iss. 6, pp. 114285-114285
Open Access | Times Cited: 2
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition: The Big Step Forward in Lipid Control
Rishi Rikhi, Michael D. Shapiro
European Cardiology Review (2023) Vol. 18
Open Access | Times Cited: 6
Synthesis of a Complex and Highly Potent PCSK9 Inhibitor
Jeffrey T. Kuethe, Joshua E.-Y. Lee, David A. Thaisrivongs, et al.
Organic Letters (2023) Vol. 25, Iss. 27, pp. 5001-5005
Closed Access | Times Cited: 6
Chromogranin A and its derived peptides: potential regulators of cholesterol homeostasis
Dhanya R. Iyer, Janani Venkatraman, Émeline Tanguy, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 9
Open Access | Times Cited: 5
Acute Coronary Syndrome: Disparities of Pathophysiology and Mortality with and without Peripheral Artery Disease
Flavius-Alexandru Gherasie, M Popescu, D. Bartos
Journal of Personalized Medicine (2023) Vol. 13, Iss. 6, pp. 944-944
Open Access | Times Cited: 4
Recent progress on total synthesis of cyclic peptides
Haiping Liu, Leiyang Bai, Xuefeng Jiang
Tetrahedron Letters (2024), pp. 155314-155314
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top